Comparing Cross-Linked and Non-Cross-Linked Hyaluronic Acid for Early Healing After Tooth Extraction

November 3, 2026 updated by: omran nasab, Cyprus Health and Social Sciences University

Effect of Cross-Linked vs Non-Cross-Linked Hyaluronic Acid on Early Soft Tissue Healing After Tooth Extraction: A Randomized Blinded Clinical Trial

This study compares early healing after a non-surgical tooth extraction in adults. Participants are assigned by chance to one of three groups: cross-linked hyaluronic acid placed in the extraction site using a gelatin sponge; non-cross-linked hyaluronic acid placed using a gelatin sponge; or a gelatin sponge alone. The study team measures the wound area using photographs at the time of extraction and on days 3, 7, and 14. A clinician who does not know the assigned group also assesses healing. Participants report their pain and use of pain-relief medicine. The study compares healing among the three groups.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mórfou, Cyprus, 99750
        • Cyprus Health and Social Sciences University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18-45 years
  • Systemically healthy
  • Light smokers, instructed to abstain completely from smoking for the first 72 postoperative hours
  • Requiring simple posterior tooth extraction
  • Clinically achievable hemostasis

Exclusion Criteria:

  • Systemic diseases affecting healing
  • Pregnancy or lactation
  • Acute infection at the extraction site
  • Use of anti-inflammatory or immunosuppressive drugs
  • Surgical extraction requiring flap elevation or bone removal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cross-Linked HA + Gelatin Sponge

Participants receive cross-linked hyaluronic acid delivered via a gelatin sponge after non-surgical tooth extraction.

Cross-linked sodium hyaluronate 1% applied locally to the extraction socket using a gelatin sponge after non-surgical tooth extraction.

Gelatin sponge placed in the extraction socket without hyaluronic acid after non-surgical tooth extraction.

Experimental: Non-Cross-Linked HA + Gelatin Sponge

Participants receive non-cross-linked hyaluronic acid delivered via a gelatin sponge after non-surgical tooth extraction.

Gelatin sponge placed in the extraction socket without hyaluronic acid after non-surgical tooth extraction.

Non-cross-linked low-molecular-weight hyaluronic acid applied locally to the extraction socket using a gelatin sponge after non-surgical tooth extraction.

Active Comparator: Gelatin Sponge Alone

Participants receive a gelatin sponge alone after non-surgical tooth extraction.

Gelatin sponge placed in the extraction socket without hyaluronic acid after non-surgical tooth extraction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ercentage Reduction in Wound Area
Time Frame: Postoperative days 0, 3, 7, and 14

Wound area will be measured from standardized, calibrated clinical photographs using ImageJ. Percentage reduction will be calculated relative to baseline: [(baseline wound area - follow-up wound area) / baseline wound area] × 100. Results will be compared among the three groups over time.

Postoperative days 0, 3, 7, and 14

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound Healing Score (WHS)
Time Frame: Postoperative days 3, 7, and 14

Clinical wound healing will be assessed using the study's WHS, with a total score ranging from 0 to 9.

Postoperative days 3, 7, and 14
Index of Postoperative Recovery (IPR)
Time Frame: Postoperative days 3, 7, and 14

Postoperative recovery will be assessed using the IPR measure specified in the study protocol.

Postoperative days 3, 7, and 14
Postoperative Pain Intensity
Time Frame: Postoperative days 1, 3, and 7

Pain intensity will be recorded using a 10-cm visual analogue scale (VAS), where 0 indicates no pain and 10 indicates the worst pain.

Postoperative days 1, 3, and 7
Postoperative Analgesic Consumption
Time Frame: Postoperative days 1-7

The number of analgesic doses taken by each participant will be recorded in the postoperative medication log.

Postoperative days 1-7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 5, 2026

Primary Completion (Actual)

November 3, 2026

Study Completion (Actual)

November 3, 2026

Study Registration Dates

First Submitted

October 21, 2026

First Submitted That Met QC Criteria

October 21, 2026

First Posted (Actual)

October 27, 2026

Study Record Updates

Last Update Posted (Actual)

November 4, 2026

Last Update Submitted That Met QC Criteria

November 3, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KSTU//2026/026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.